Synagis

Made by

• Abbott Laboratories

Active Ingredient

Palivizumab

Prospectus

Approval date

2002/1/17

Treats

• Respiratory syncytial virus infection, RSV infection

Dosages

• SYNAGIS Solution for intramuscular Administration - 57762円／瓶

• SYNAGIS Solution for intramuscular Administration - 113993円／瓶